Aperio Group’s Rubius Therapeutics, Inc RUBY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$179K Buy
23,550
+3,622
+18% +$27.5K ﹤0.01% 2325
2020
Q3
$100K Sell
19,928
-4,016
-17% -$20.2K ﹤0.01% 2322
2020
Q2
$143K Buy
23,944
+12,527
+110% +$74.8K ﹤0.01% 2237
2020
Q1
$51K Buy
+11,417
New +$51K ﹤0.01% 2278